Salt Lake City, UT, United States of America

Puskar Mishra

This inventor holds 1 USPTO granted patent. Top assignee: Circa Scientific, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Puskar Mishra. Retrieved from https://idiyas.com/inventor/puskar-mishra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Puskar Mishra and Tissue Engagement Technology.

Introduction

Puskar Mishra is an inventor based in Salt Lake City, Utah. His patent work includes a tissue engagement device designed to help engage and anchor a targeted tissue layer.

Latest Patents

Mishra is associated with 1 patent, titled “Tissue Engagement Devices, Systems, and Methods.” The disclosed device includes a sheath, two arms with tissue-engaging members, and an actuation cannula that moves between retracted and extended positions. In the extended position, the cannula guides portions of the arms into the space between the cannula and the sheath. The engaging members are configured to pierce and anchor to the desired tissue layer.

Career Highlights

Mishra is associated with Circa Scientific, Inc. His patent describes a coordinated mechanism for positioning tissue-engaging members and anchoring them to a selected tissue layer.

Collaborations

Mishra’s listed coworker is Kevin Jerry Cook. The available information identifies their professional association but does not specify the details of their collaboration.

Conclusion

Puskar Mishra’s patent focuses on a tissue engagement system that combines an actuation cannula, paired arms, and tissue-engaging members to support targeted tissue anchoring.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…